What Happened to Outsourcing in Asia? Last year, industry research pointed to China and India as the industry's top potential destinations for offshoring over the next five years, which put them ahead of traditional biomanufacturing hubs in the US and Western Europe. China was seen as a favorite likely destination for both US and European respondents to prior studies, with India close behind. But a new report suggests that that enthusiasm might be waning ...Read more
Is Pinterest the Risk-Free Social Channel for Pharma? Pinterest was recently declared the “safest place” for medical marketers to start with social media. All too aware that there are many Pharma marketers out there still a little shy of social, Peter Houston investigates if the statement is true ... Read more
Drug Development: To Sue or Not to Sue While it may not happen often, clinical trials can sometimes be halted by patent disputes, leading to costly delays in bringing new drugs to market. But the UK Government has decided to do something about this in a bid to make UK patent law more consistent with that in some other parts of the world, writes Dr Nicholas Jones ... Read more
2013: Unlocking the Key to Public Funding in Brazil The Brazilian Ministry of Health recently announced plans to spend $17 billion on drugs between 2013 and 2016. Significantly, 40 percent of current federal spending on drugs is on innovative biologics. This not a race-to-the-bottom pool comprised exclusively of cheap generics. For this reason alone, the actions of the government on this new strategic approach to health technology assessment should be followed closely in the industry C-suite ... Read more
Products/Services Profiles
Sciformix
SciVigilance – Pharmacovigilance in a box
Scivigilance provides the powerful combination of streamlined processes, domain expertise and robust technology that integrates disparate data and enables the seamless flow, collection processing and analysis of data. Scivigilance delivers significant time and cost savings, efficiency and compliance gains, all while delivering the highest quality outcomes. Read More
